BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25862488)

  • 1. Focal adhesion kinase and p53 synergistically decrease neuroblastoma cell survival.
    Gillory LA; Stewart JE; Megison ML; Waters AM; Beierle EA
    J Surg Res; 2015 Jun; 196(2):339-49. PubMed ID: 25862488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of FAK and VEGFR-3 binding decreases tumorigenicity in neuroblastoma.
    Stewart JE; Ma X; Megison M; Nabers H; Cance WG; Kurenova EV; Beierle EA
    Mol Carcinog; 2015 Jan; 54(1):9-23. PubMed ID: 23868727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interaction between FAK, MYCN, p53 and Mdm2 in neuroblastoma.
    Waters AM; Beierle EA
    Anticancer Agents Med Chem; 2014 Jan; 14(1):46-51. PubMed ID: 24041229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting focal adhesion kinase in neuroblastoma.
    Gillory L; Beierle EA
    Anticancer Agents Med Chem; 2010 Dec; 10(10):714-21. PubMed ID: 21269252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MYCN, neuroblastoma and focal adhesion kinase (FAK).
    Beierle EA
    Front Biosci (Elite Ed); 2011 Jan; 3(2):421-33. PubMed ID: 21196322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal adhesion kinase and p53 signal transduction pathways in cancer.
    Golubovskaya VM; Cance W
    Front Biosci (Landmark Ed); 2010 Jun; 15(3):901-12. PubMed ID: 20515733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focal adhesion kinase versus p53: apoptosis or survival?
    Cance WG; Golubovskaya VM
    Sci Signal; 2008 May; 1(20):pe22. PubMed ID: 18493017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FAK and p53 protein interactions.
    Golubovskaya VM; Cance WG
    Anticancer Agents Med Chem; 2011 Sep; 11(7):617-9. PubMed ID: 21355845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of focal adhesion kinase decreases tumor growth in human neuroblastoma.
    Beierle EA; Ma X; Stewart J; Nyberg C; Trujillo A; Cance WG; Golubovskaya VM
    Cell Cycle; 2010 Mar; 9(5):1005-15. PubMed ID: 20160475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct interaction of the N-terminal domain of focal adhesion kinase with the N-terminal transactivation domain of p53.
    Golubovskaya VM; Finch R; Cance WG
    J Biol Chem; 2005 Jul; 280(26):25008-21. PubMed ID: 15855171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FAK inhibition decreases cell invasion, migration and metastasis in MYCN amplified neuroblastoma.
    Megison ML; Stewart JE; Nabers HC; Gillory LA; Beierle EA
    Clin Exp Metastasis; 2013 Jun; 30(5):555-68. PubMed ID: 23208732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FAK deletion promotes p53-mediated induction of p21, DNA-damage responses and radio-resistance in advanced squamous cancer cells.
    Graham K; Moran-Jones K; Sansom OJ; Brunton VG; Frame MC
    PLoS One; 2011; 6(12):e27806. PubMed ID: 22194793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted Modulation of FAK/PI3K/PDK1/AKT and FAK/p53 Pathways by Cucurbitacin B for the Antiproliferation Effect Against Human Cholangiocarcinoma Cells.
    Klungsaeng S; Kukongviriyapan V; Prawan A; Kongpetch S; Senggunprai L
    Am J Chin Med; 2020; 48(6):1475-1489. PubMed ID: 32907364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FAK and Nanog cross talk with p53 in cancer stem cells.
    Golubovskaya VM
    Anticancer Agents Med Chem; 2013 May; 13(4):576-80. PubMed ID: 22934707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal adhesion kinase and p53 signaling in cancer cells.
    Golubovskaya VM; Cance WG
    Int Rev Cytol; 2007; 263():103-53. PubMed ID: 17725966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct FAK-Src activation events promote alpha5beta1 and alpha4beta1 integrin-stimulated neuroblastoma cell motility.
    Wu L; Bernard-Trifilo JA; Lim Y; Lim ST; Mitra SK; Uryu S; Chen M; Pallen CJ; Cheung NK; Mikolon D; Mielgo A; Stupack DG; Schlaepfer DD
    Oncogene; 2008 Feb; 27(10):1439-48. PubMed ID: 17828307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning and characterization of the promoter region of human focal adhesion kinase gene: nuclear factor kappa B and p53 binding sites.
    Golubovskaya V; Kaur A; Cance W
    Biochim Biophys Acta; 2004 May; 1678(2-3):111-25. PubMed ID: 15157737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin plays a key regulatory role via a p53/FAK-dependent signaling in melanoma cell adhesion and migration.
    Chalkiadaki G; Nikitovic D; Berdiaki A; Katonis P; Karamanos NK; Tzanakakis GN
    IUBMB Life; 2011 Feb; 63(2):109-19. PubMed ID: 21360640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53-Dependent repression of focal adhesion kinase in response to estradiol in breast cancer cell-lines.
    Anaganti S; Fernández-Cuesta L; Langerød A; Hainaut P; Olivier M
    Cancer Lett; 2011 Jan; 300(2):215-24. PubMed ID: 21071137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unraveling the relationship between n-myc and Focal Adhesion Kinase (FAK) in neuroblastoma?
    Madonna MB
    Cell Cycle; 2010 May; 9(9):1679-80. PubMed ID: 20448460
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.